GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)
India · Delayed Price · Currency is INR 2,958.60
+23.25 (0.79%)
At close: Sep 4, 2026
BOM:500660 Market Cap
BOM:500660 has a market cap or net worth of 501.2 billion as of September 4, 2026. Its market cap has increased by 6.68% in one year.
Market Cap
501.20B
Enterprise Value
473.97B
Revenue
39.55B
Ranking
n/a
PE Ratio
46.92
Stock Price
2,958.60
ChartMarket Cap Chart
Since October 25, 2001, BOM:500660's market cap has increased from 19.14B to 501.20B, an increase of 2,518.61%. That is a compound annual growth rate of 14.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 501.20B | 19.74% |
| Dec 31, 2025 | 418.59B | 9.72% |
| Dec 31, 2024 | 381.50B | 18.69% |
| Dec 29, 2023 | 321.43B | 43.86% |
| Dec 30, 2022 | 223.43B | -25.08% |
| Dec 31, 2021 | 298.24B | 8.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.87T |
| Lupin | 976.20B |
| Dr. Reddy's Laboratories | 962.10B |
| Abbott India | 549.90B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Caplin Point Laboratories | 216.09B |
| Granules India | 211.61B |
| AstraZeneca Pharma India | 171.76B |